Christian Langlois

Title: Christian Langlois: Innovator in Pharmaceutical Technology

Introduction

Christian Langlois is a notable inventor based in Verrieres le Buisson, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug delivery systems. His work focuses on enhancing the efficacy and safety of medications through advanced formulations.

Latest Patents

Christian Langlois holds a patent for "Pharmaceutical microspheres containing valproic acid for oral administration." This invention involves pharmaceutical microspheres that utilize a mixture of valproic acid and its pharmaceutically acceptable salts, combined with a matrix vehicle selected from glycerol esters, hydrogenated oils, esterified polyethylene glycols, waxes, and their mixtures. This innovative approach aims to improve the oral administration of valproic acid, a medication commonly used for epilepsy and bipolar disorder.

Career Highlights

Christian Langlois is associated with Sanofi-Synthelabo, a leading global healthcare company. His work at Sanofi-Synthelabo has allowed him to contribute to the development of cutting-edge pharmaceutical technologies. With a focus on research and innovation, he has played a crucial role in advancing drug formulations that benefit patients worldwide.

Collaborations

Christian Langlois has collaborated with Jean-Yves Lanne, a fellow professional in the pharmaceutical industry. Their partnership has fostered the exchange of ideas and expertise, leading to advancements in drug delivery systems.

Conclusion

Christian Langlois is a prominent figure in the pharmaceutical industry, recognized for his innovative contributions to drug formulation. His patent for pharmaceutical microspheres containing valproic acid exemplifies his commitment to improving patient care through advanced technology.